扩展乳腺癌症监测联盟浸润性乳腺癌模型
研究将BCSC v2浸润性乳腺癌风险模型扩展为v3,纳入BMI、扩展家族史和首次活产年龄,在1,455,493名35-79岁无乳腺癌史女性中评估。v3模型5年风险的E/O为1.03(95%CI 1.01-1.04),AUROC为0.646;BMI 30.0-34.9 kg/m²女性5年风险≥3%的真阳性率从v2的10.0%升至v3的19.8%。
要点
- BCSC v3模型在v2基础上纳入BMI、扩展家族史和首次活产年龄。
- v3模型5年风险E/O为1.03(95%CI 1.01-1.04),AUROC为0.646。
- BMI 30.0-34.9 kg/m²女性5年风险≥3%真阳性率v2为10.0%、v3为19.8%。
核心结论
- BCSC v3模型更新了已良好校准和验证的乳腺癌风险评估工具,纳入更多重要风险因素。
- 纳入BMI与个体女性估计风险的最大改善相关。
研究设计与样本
- 在BCSC队列中使用Cox比例风险回归估计年龄和种族/民族特异性的相对风险。
- 分析1,455,493名35-79岁无乳腺癌史女性,平均随访7.3年,30,266名诊断为浸润性乳腺癌。
- 通过期望与观察(E/O)比值评估校准,通过受试者工作特征曲线下面积(AUROC)评估区分度。
主要发现
- v3模型5年风险的E/O为1.03(95%CI 1.01-1.04),AUROC为0.646。
- 与v2模型相比,v3模型的区分度在亚洲、白人和黑人女性中改善最大。
- BMI 30.0-34.9 kg/m²女性中,估计5年风险≥3%的真阳性率从v2的10.0%升至v3的19.8%。
- BMI≥35 kg/m²女性中改善更大,真阳性率从7.6%升至19.8%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We extended the Breast Cancer Surveillance Consortium (BCSC) version 2 (v2) model of invasive breast cancer risk to include BMI, extended family history of breast cancer, and age at first live birth (version 3 [v3]) to better inform appropriate breast cancer prevention therapies and risk-based screening. METHODS: We used Cox proportional hazards regression to estimate the age- and race- and ethnicity-specific relative hazards for family history of breast cancer, breast density, history of benign breast biopsy, BMI, and age at first live birth for invasive breast cancer in the BCSC cohort. We evaluated calibration using the ratio of expected-to-observed (E/O) invasive breast cancers in the cohort and discrimination using the area under the receiver operating characteristic curve (AUROC). RESULTS: We analyzed data from 1,455,493 women age 35-79 years without a history of breast cancer. During a mean follow-up of 7.3 years, 30,266 women were diagnosed with invasive breast cancer. The BCSC v3 model had an E/O of 1.03 (95% CI, 1.01 to 1.04) and an AUROC of 0.646 for 5-year risk. Compared with the v2 model, discrimination of the v3 model improved most in Asian, White, and Black women. Among women with a BMI of 30.0-34.9 kg/m2, the true-positive rate in women with an estimated 5-year risk of 3% or higher increased from 10.0% (v2) to 19.8% (v3) and the improvement was greater among women with a BMI of ≥35 kg/m2 (7.6%-19.8%). CONCLUSION: The BCSC v3 model updates an already well-calibrated and validated breast cancer risk assessment tool to include additional important risk factors. The inclusion of BMI was associated with the largest improvement in estimated risk for individual women.
引用
- Gard CC, Tice JA, Miglioretti DL, et al. Extending the Breast Cancer Surveillance Consortium Model of Invasive Breast Cancer. J Clin Oncol. 2023. PMID: 37976443. doi:10.1200/JCO.22.02470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。